Cardiotoxicity in 5-Fluorouracil–Folinic Acid Treatment for Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 2296-5262|21|4|324-327

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.4, 1998-09, pp. : 324-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

An Alternating Regimen of Irinotecan/ 5-Fluorouracil/Folinic Acid and Oxaliplatin/ 5-Fluorouracil/Folinic Acid in Metastatic Colorectal Cancer: A Phase II Trial

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 283-289

Karger

Access to resources Recommend Favorite

Phase II Study of a Weekly 24-Hour Infusion with 5-Fluorouracil and Simultaneous Sodium – Folinic Acid in the First-Line Treatment of Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 457-462

Karger

Access to resources Recommend Favorite

Neoadjuvant Treatment with Weekly High-Dose 5-Fluorouracil as 24-Hour Infusion, Folinic Acid and Oxaliplatin in Patients with Primary Resectable Liver Metastases of Colorectal Cancer

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Sequential Trimetrexate, 5-Fluorouracil and Folinic Acid Are Effective and Well Tolerated in Metastatic Colorectal Carcinoma

By  

Oncology, Vol. 58, Iss. 4, 2000-05 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

5-Fluorouracil, Folinic Acid and Oxaliplatin Administered via Hepatic Arterial Infusion as Regional Second-Line Therapy for Advanced Colorectal Cancer

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 473-474

Karger

Access to resources Recommend Favorite